Clinical trial
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the…
NCT00196378 · Duramed Research, Industry · Completed
Key facts
| NCT number | NCT00196378 |
|---|---|
| Title | A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy |
| Official title | A Randomized, Multicenter, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Synthetic Conjugated Estrogens, B (Enjuvia) 0.3 mg Tablets for the Treatment of Vulvovaginal Atrophy in Healthy Postmenopausal Women |
| Lead sponsor | Duramed Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause |
| Intervention type | Drug, Other |
| Interventions | Synthetic Conjugated estrogens, B, Placebo |
| Enrollment | 300 |
| Start date | Nov 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 2, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: